On 21 May 2026, Yidu Tech Inc. (Yidu Tech) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., secured the tender to construct an intelligent clinical research integrated platform for Tianjin Medical University Cancer Institute and Hospital. The project is valued at approximately RMB 7.39 million.

According to the announcement, the platform will embed Yidu Tech’s proprietary artificial-intelligence capabilities designed to mirror physicians’ clinical decision-making and model real-world disease progression. The company expects the system to support more precise, efficient diagnoses and treatments while enhancing research efficiency for the hospital.

Yidu Tech positions the win as further evidence of its role in advancing intelligent healthcare solutions across China’s medical ecosystem, which spans healthcare services, pharmaceutical development, insurance and patient care.

The board of Yidu Tech is chaired by Executive Director Ms. Gong Yingying. The announcement did not disclose additional financial metrics or implementation timelines for the project.